- New
-
Topics
- All Categories
- Metaphysics and Epistemology
- Value Theory
- Science, Logic, and Mathematics
- Science, Logic, and Mathematics
- Logic and Philosophy of Logic
- Philosophy of Biology
- Philosophy of Cognitive Science
- Philosophy of Computing and Information
- Philosophy of Mathematics
- Philosophy of Physical Science
- Philosophy of Social Science
- Philosophy of Probability
- General Philosophy of Science
- Philosophy of Science, Misc
- History of Western Philosophy
- Philosophical Traditions
- Philosophy, Misc
- Other Academic Areas
- Journals
- Submit material
- More
The Future of the Pharmaceutical Industry: Beyond Government-Granted Monopolies
Journal of Law, Medicine and Ethics 49 (1):25-29 (2021)
Abstract
Just as tariffs lead to economic distortions and provide incentives for corruption, so do patent monopolies on prescription drugs, except the impact is often an order of magnitude larger.My notes
Similar books and articles
Cured to Death: The Effects of Prescription Drugs.Arabella Melville & Colin Johnson - 1983 - Stein & Day.
Five Un-Easy Pieces of Pharmaceutical Policy Reform.Marc A. Rodwin - 2013 - Journal of Law, Medicine and Ethics 41 (3):581-589.
Government Support of Meaningful Drug and Device Innovation: Pathways and Challenges.Aaron S. Kesselheim - 2023 - Journal of Law, Medicine and Ethics 51 (S2):7-15.
Wirtschaftsethik Und Monopole Im Fünfzehnten Und Sechzehnten Jahrhundert.Joseph Höffner - 1941 - G. Fischer.
Corruption of Pharmaceutical Markets: Addressing the Misalignment of Financial Incentives and Public Health.Marc-André Gagnon - 2013 - Journal of Law, Medicine and Ethics 41 (3):571-580.
Curbing Misconduct in the Pharmaceutical Industry: Insights from Behavioral Ethics and the Behavioral Approach to Law.Yuval Feldman, Rebecca Gauthier & Troy Schuler - 2013 - Journal of Law, Medicine and Ethics 41 (3):620-628.
Institutional Corruption and the Pharmaceutical Policy.Marc A. Rodwin - 2013 - Journal of Law, Medicine and Ethics 41 (3):544-552.
Pharmaceutical medicine.D. M. Burley & Theodore Barker Binns (eds.) - 1985 - Baltimore, Md., U.S.A.: E. Arnold.
Where Strategy and Ethics Converge: Pharmaceutical Industry Pricing Policy for Medicare Part D Beneficiaries.Edward R. Balotsky - 2009 - Journal of Business Ethics 84 (S1):75 - 88.
Analytics
Added to PP
2021-04-22
Downloads
28 (#556,922)
6 months
5 (#837,449)
2021-04-22
Downloads
28 (#556,922)
6 months
5 (#837,449)
Historical graph of downloads
Citations of this work
Development of a National Public Pharmaceutical Research and Development Institute.Ameet Sarpatwari, Dana Brown & Aaron S. Kesselheim - 2020 - Journal of Law, Medicine and Ethics 48 (1):225-227.
INTRODUCTION: Public Sector and Non-Profit Contributions to Drug Development — Historical Scope, Opportunities, and Challenges.Ameet Sarpatwari & Aaron S. Kesselheim - 2021 - Journal of Law, Medicine and Ethics 49 (1):6-9.
PhilPapers logo by Andrea Andrews and Meghan Driscoll.
This site uses cookies and Google Analytics (see our terms & conditions for details regarding the privacy implications). Use of this site is subject to terms & conditions.
All rights reserved by The PhilPapers Foundation
Server: philpapers-web-6686886f5-7g5mb uwo